JULPHAR · Ratios · TradingHolo

Markets › UAE › ADX › JULPHAR

Gulf Pharmaceutical Industries PSC

ADX:JULPHARHealth TechnologyADX:FADGIADX:FADXSI

AED 0.9790−0.20%At closeAt close · Mon 19 Oct · Market cap $308.59M · Next earnings Thu 5 Nov

🔔 Alert▶ Test a strategy

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Gross margin	26.6%	29.9%	30.9%	33.3%	33.7%	38.1%		+4.5 pts
Operating margin	−36.7%	−5.6%	−6.0%	−2.6%	3.9%	4.8%		+0.9 pts
Net margin	−51.2%	3.2%	−1.8%	−7.8%	0.7%	5.7%		+5.0 pts
EBITDA margin	−19.5%	3.5%	2.1%	8.5%	17.5%	10.2%		−7.4 pts
Return on equity	−32.5%	3.8%	−3.2%	−12.5%	0.9%	6.4%		+5.5 pts
Return on assets	−12.6%	1.5%	−1.2%	−4.0%	0.3%	3.4%		+3.1 pts
Return on capital employed	−15.5%	−3.6%	−5.4%	−1.9%	2.5%	4.0%		+1.4 pts
Debt / equity	0.7×	0.9×	1.0×	1.4×	1.2×	0.3×		−76.5%
Debt / assets	26.3%	33.8%	36.9%	45.3%	40.0%	15.5%		−24.6 pts
Interest coverage	−5.9×	−2.3×	−2.4×	−0.6×	0.6×	1.7×		+178.1%
Current ratio	1.2×	2.3×	2.4×	2.3×	2.3×	3.1×		+37.7%
Quick ratio	0.8×	1.2×	1.3×	1.3×	1.7×	2.2×		+30.2%
Cash ratio	0.1×	0.2×	0.2×	0.3×	0.2×	0.5×		+151.8%
Asset turnover	0.2×	0.5×	0.7×	0.5×	0.4×	0.6×		+47.7%
Inventory turnover	1.3×	1.1×	1.7×	1.3×	1.3×	1.6×		+17.1%
Receivables turnover	0.9×	2.0×	2.5×	2.1×	1.2×	2.1×		+77.6%
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%		—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ